| 摘要 |
<p>Synergistic combination of a macrolide T -cell immunomodulator or immunosuppressant such as 33-epichloro-33desoxyascomycin and a ceramide such as ceramide 3, LPC-9S or linoleic acid are provided, which are useful in particular in the treatment of dermatological or mucosal diseases such as atopic or contact dermatitis or dry skin, asteatotic eczema or xerosis.</p> |
